UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin

Watkins, Rachel J; Imruetaicharoenchoke, Waraporn; Read, Martin L; Sharma, Neil; Poole, Vikki L; Gentilin, Erica; Bansal, Sukhchain; ... McCabe, Christopher J; + view all (2016) Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin. The Journal of Clinical Endocrinology & Metabolism , 101 (12) pp. 4551-4563. 10.1210/jc.2016-1932. Green open access

[thumbnail of Hackshaw_jcem4551.pdf]
Preview
Text
Hackshaw_jcem4551.pdf

Download (4MB) | Preview

Abstract

Context: Metastatic disease is responsible for the majority of endocrine cancer deaths. New therapeutic targets are urgently needed to improve patient survival rates. // Objective: The proto-oncogene PTTG1-binding factor (PBF/PTTG1IP) is overexpressed in multiple endocrine cancers and circumstantially associated with tumor aggressiveness. This study aimed to understand the role of PBF in tumor cell invasion and identify possible routes to inhibit its action. // Design, Setting, Patients, and Interventions: Thyroid, breast, and colorectal cells were transfected with PBF and cultured for in vitro analysis. PBF and cortactin (CTTN) expression was determined in differentiated thyroid cancer and The Cancer Genome Atlas RNA-seq data. // Primary Outcome Measure: Pro-invasive effects of PBF were evaluated by 2D Boyden chamber, 3D organotypic, and proximity ligation assays. // Results: Our study identified that PBF and CTTN physically interact and co-localize, and that this occurs at the cell periphery, particularly at the leading edge of migrating cancer cells. Critically, PBF induces potent cellular invasion and migration in thyroid and breast cancer cells, which is entirely abrogated in the absence of CTTN. Importantly, we found that CTTN is over-expressed in differentiated thyroid cancer, particularly in patients with regional lymph node metastasis, which significantly correlates with elevated PBF expression. Mutation of PBF (Y174A) or pharmacological intervention modulates the PBF: CTTN interaction and attenuates the invasive properties of cancer cells. // Conclusion: Our results demonstrate a unique role for PBF in regulating CTTN function to promote endocrine cell invasion and migration, as well as identify a new targetable interaction to block tumor cell movement.

Type: Article
Title: Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1210/jc.2016-1932
Publisher version: https://doi.org/10.1210/jc.2016-1932
Language: English
Additional information: Copyright © 2016 by the Endocrine Society. This article has been published under the terms of the Creative Commons Attribution License (CC-BY; https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s).
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre
URI: https://discovery.ucl.ac.uk/id/eprint/10205089
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item